Index of reports
> Cases with Uterine Leiomyoma (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace (Megestrol) where reactions include uterine leiomyoma. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Anaemia, Uterine Leiomyoma, Gastrooesophageal Reflux Disease, Decreased Appetite, Hypokalaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Axitinib (Axitinib)
Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Axitinib (Axitinib)
Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Carboplatin
Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Carboplatin
Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Paclitaxel
Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Paclitaxel
Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d), oral;
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Celecoxib
Dosage: 200 mg (200 mg, 1 in 1 d), oral; 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Megace
Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Megace
Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-11-28
Other drugs received by patient: Benadryl; MS Contin; Zofran; Wellbutrin
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-16
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia, Vaginal Haemorrhage
Drug(s) suspected as cause:
Megace
Dosage: 5 cc (5,4 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-11-28
Megace
Dosage: 5 cc (5,4 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Celecoxib
Dosage: 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Paclitaxel
Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Carboplatin
Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Axitinib (Axitinib)
Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Other drugs received by patient: Wellbutrin (Bupropion0; Benadryl; Zofran; MS Contin
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Decreased Appetite, Vaginal Haemorrhage, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Axitinb (Axitinib)
Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Axitinb (Axitinib)
Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Carboplatin
Dosage: 26.9048 mg (565 mg,1 in 3 wk),intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Megace
Dosage: 5 cc (5, 4 in 1 d),oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Metoprolol Tartrate
Dosage: 25 mg (25 mg,1 in 1 d),oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Celecoxib
Dosage: 200 mg (200 mg,1 in 1 d),oral ; 200 mg (200 mg,1 in 1 d),oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d),oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Paclitaxel
Dosage: 10.2381 mg (215 mg,1 in 3 wk),intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Other drugs received by patient: Benadryl; MS Contin; Wellbutrin; Zofran
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-24
Patient: 56 year old female, weighing 65.9 kg (145.0 pounds)
Reactions: Uterine Leiomyoma, Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Axitinib (Axitinib)
Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Celebrix (Celecoxib)
Dosage: 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Menopause
Start date: 1997-01-01
End date: 2011-11-01
Prempro
Dosage: 0.625 mg/2.5 mg (1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Carboplatin
Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-20
Paclitaxel
Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-20
Megace
Dosage: 5 cc (1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Other drugs received by patient: Benadryl; Wellbutrin; Zofran; MS Contin; Megace; Celebrex
|